Evidence map›Paper›PMID 37977094›Full record

Observational studyJournal of psychosomatic research2024

Generalized anxiety is a predictor of impaired quality of life in patients with atrial fibrillation: Findings from the prospective observational ARENA study.

Monika Sadlonova, Stefan Salzmann, Jochen Senges, Christopher M Celano, Jeff C Huffman, Martin Borggrefe, Ibrahim Akin, Dierk Thomas, Christopher Jan Schwarzbach, Thomas Kleemann and 8 more

Registry-linked trialAbstract readObservational StudyMulticenter Study
In one paragraph

Observational study in Journal of psychosomatic research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02978248 (Af Register RhEin NeckAr - Projekt Vorhofflimmern Rhein Neckar), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02978248 completednot on this map

Af Register RhEin NeckAr - Projekt Vorhofflimmern Rhein Neckar

Typeobservational_patient_registrySponsorStiftung Institut fuer HerzinfarktforschungRan2016 to 2021Enrolled2,777ConditionsAtrial Fibrillation
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Brazilian Atrial Fibrillation Guidelines - 2025.Arquivos brasileiros de cardiologia · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Monika SadlonovaDepartment of Psychosomatic Medicine and Psychotherapy, University of Göttingen Medical Center, Göttingen, Germany; Department of Cardiovascular and Thoracic Surgery, University of Göttingen Medical Center, Göttingen, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Göttingen, Germany; Department of Psychiatry, Massachusetts General Hospital, Boston, United States; Department of Psychiatry, Harvard Medical School, Boston, United States. Electronic address: monika.sadlonova@med.uni-goettingen.de.
Stefan SalzmannDepartment of Clinical Psychology and Psychotherapy, Philipps-University Marburg, Germany; Medical Psychology, Health and Medical University Erfurt, Germany.
Jochen SengesInstitute of Myocardial Infarction Research, Hospital of Ludwigshafen, Ludwigshafen, Germany.
Christopher M CelanoDepartment of Psychiatry, Massachusetts General Hospital, Boston, United States; Department of Psychiatry, Harvard Medical School, Boston, United States.
Jeff C HuffmanDepartment of Psychiatry, Massachusetts General Hospital, Boston, United States; Department of Psychiatry, Harvard Medical School, Boston, United States.
Martin BorggrefeDepartment of Cardiology, Pneumology, Angiology, and Emergency Medicine, University of Mannheim Medical Center, Mannheim, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Heidelberg/Mannheim, Germany.
Ibrahim AkinDepartment of Cardiology, Pneumology, Angiology, and Emergency Medicine, University of Mannheim Medical Center, Mannheim, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Heidelberg/Mannheim, Germany.
Dierk ThomasGerman Center for Cardiovascular Research (DZHK), Partner Site Heidelberg/Mannheim, Germany; Department of Internal Medicine III - Cardiology, Angiology and Pneumology, Medical University, Hospital Heidelberg, Germany.
Christopher Jan SchwarzbachDepartment of Neurology, Hospital of Ludwigshafen, Ludwigshafen, Germany.
Thomas KleemannHospital of Ludwigshafen, Ludwigshafen, Germany.
Steffen SchneiderInstitute of Myocardial Infarction Research, Hospital of Ludwigshafen, Ludwigshafen, Germany.
Matthias HochadelInstitute of Myocardial Infarction Research, Hospital of Ludwigshafen, Ludwigshafen, Germany.
Tim SüselbeckClinic of Cardiology, Ludwigshafen, Germany.
Harald SchwackeDiakonissen-Stiftungs-Hospital Speyer, Speyer, Germany.
Angelika AlonsoDepartment of Neurology, Mannheim Center for Translation Neuroscience, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Markus HaassDepartment of Cardiology, Theresien Hospital and St. Hedwig Clinic GmbH, Mannheim, Germany.
Karl-Heinz LadwigDepartment of Psychosomatic Medicine and Psychotherapy, University Hospital rechts der Isar, Technical University Munich, Munich, Germany; German Centre for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany.
Christoph Herrmann-LingenDepartment of Psychosomatic Medicine and Psychotherapy, University of Göttingen Medical Center, Göttingen, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Göttingen, Germany.

Funding

A novel behavioral intervention to promote adherence in heart failureR01HL155301 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI CELANO, CHRISTOPHER M · 2021 to 2025
$3.8M
NHLBI NIH HHS R01 HL155301
6 · The paper itself

Abstract

objectiveAtrial fibrillation (AF) is associated with impaired health-related quality of life (HRQoL), an increased risk of morbidity, and mortality. Traditional AF-related outcomes (e.g., AF recurrence) primarily demonstrate the physiological benefits of AF management but do not focus on the benefits experienced subjectively by the patient (i.e., patient-reported outcomes), which have been suggested as optimal endpoints in AF intervention studies. The aim of this study is to identify medical and psychological factors associated with impaired HRQoL at 1-year follow-up.

methodsUsing data from the prospective observational multicenter ARENA study in patients with AF, we analyzed associations between medical factors, anxiety, and HRQoL at 1-year follow-up assessed using 5-level EuroQoL-5D.

resultsIn 1353 AF patients (mean age 71.4 ± 10.3 years, 33.8% female), none of the medical predictors (e.g., heart disease) or history of cardioversion were associated with HRQoL at the 1-year follow-up. Higher generalized anxiety (β = -0.114, p < .001) but not cardiac anxiety (β = -0.006, p = .809) at baseline predicted decreased HRQoL, independent of confounding variables and patients' medical status. Furthermore, the worsening of patients' generalized anxiety was associated with decreased HRQoL (ß = -0.091, p < .001). In contrast, the improvement of generalized anxiety over time predicted higher HRQoL (ß = 0.097, p < .001). Finally, the worsening of patients' cardiac anxiety over time was associated with decreased HRQoL (ß = -0.081, p < .001).

conclusionOur results highlight the importance of anxiety as a predictor of future HRQoL in patients with AF. Additional studies to examine the impact of anxiety treatment on HRQoL in this population are needed. CLINICAL

trial registrationThe investigators registered on ClinicalTrials.gov (NCT02978248) on November 30, 2016 https://clinicaltrials.gov/ct2/show/NCT02978248.

Indexed as

Atrial FibrillationAgedAged, 80 and overAnxietyFemaleHumansMaleMiddle AgedPatientsProspective StudiesQuality of LifeAtrial fibrillationCardiac anxietyGeneralized anxietyHealth-related quality of lifeScreening

Identifiers

PMID37977094
PMCPMC11995162

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.